HOOKIPA PHARMA INC. Operating Margin
- Operating margin · 12 months: Value -860.18%; Formula and calculation Operating income / revenue. Period ending 2025-03-31..
Operating margin
Overview →Financial period ending 2025-03-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | -860.18% | Operating income / revenue. Period ending 2025-03-31. $-80.44M ÷ $9.35M × 100 ≈ -860.18% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -80.44M USD | Operating Income (Loss) |
| Revenue | 9.35M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) | |
| Research and development | 61.20M USD | Research and Development Expense |
| Selling, general and administration | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2025-03-31 | $-80.44M | $9.35M | (m) | $61.20M | (m) | -860.18% |
| 2024-12-31 | $-51.45M | $43.95M | (m) | $68.51M | (m) | -117.09% |
| 2024-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | $-63.93M | $53.55M | (m) | $85.66M | (m) | -119.38% |
| 2023-12-31 | $-97.69M | $20.13M | (m) | $86.42M | (m) | -485.34% |
| 2023-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $-73.16M | $14.25M | (m) | $68.64M | (m) | -513.40% |
| 2022-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | $-81.67M | $18.45M | (m) | $82.85M | (m) | -442.73% |
| 2021-09-30 | (m) | $19.72M | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | $19.88M | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | $21.19M | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-09-30 | (m) | $18.04M | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | $16.04M | (m) | (m) | (m) | (m) |
| 2020-03-31 | (m) | $13.40M | (m) | (m) | (m) | (m) |
| 2019-12-31 | (m) | $11.94M | (m) | (m) | (m) | (m) |
| 2019-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | $-14.16M | (m) | (m) | $9.77M | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.